TRANexamic Acid to Reduce Bleeding in BURN Surgery
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 102
Summary
- Conditions
- Burns
- Surgery
- Tranexamic Acid
- Wounds and Injuries
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
The first aim of the study is to demonstrate that tranexamic acid help limit blood loss and reduces the use of blood products. Secondary objectives are to evaluate impact of tranexamic acid on mortality, success of skin grafts and occurrence of deep vein thrombosis or myocardial infarction.
The first aim of the study is to demonstrate that tranexamic acid help limit blood loss and reduces the use of blood products. Secondary objectives are to evaluate impact of tranexamic acid on mortality, success of skin grafts and occurrence of deep vein thrombosis or myocardial infarction.
Tracking Information
- NCT #
- NCT03113253
- Collaborators
- Société Française d'Anesthésie et de Réanimation
- Investigators
- Principal Investigator: Mathieu Fontaine, MD, PhD Saint Joseph Saint Luc Hospital, Burn Intensive Care Unit